HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.

Abstract
[This corrects the article DOI: 10.18632/oncotarget.25466.].
AuthorsVojtech Novohradsky, Juraj Zajac, Oldrich Vrana, Jana Kasparkova, Viktor Brabec
JournalOncotarget (Oncotarget) Vol. 9 Issue 85 Pg. 35599 (10 30 2018) ISSN: 1949-2553 [Electronic] United States
PMID30473754 (Publication Type: Journal Article, Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: